CIK 0001593899 · Non-accelerated filer<br>Smaller reporting company
Atea Pharmaceuticals, Inc.
Sign in to watch- Ticker
- AVIR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- MA
- Entity type
- operating
- EIN
- 460574869
- Phone
- (857) 284-8891
- Business address
- 225 FRANKLIN STREET, SUITE 2100, BOSTON, MA, 02110
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Option exercise Director acquired 29,600 shares (option exercise)
- 4 Option exercise Director acquired 29,600 shares (option exercise)
- 4 Option exercise Director acquired 29,600 shares (option exercise)
- 4 Option exercise Director acquired 29,600 shares (option exercise)
- 4 Option exercise Director acquired 29,600 shares (option exercise)
- 4 Option exercise Director acquired 29,600 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 8-K Event Shareholder vote results
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- DEF 14A Proxy Proxy Statement
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 8-K Event Material agreement · Results of operations · Executive or director change · Regulation FD disclosure
- DEFA14A Proxy Proxy Materials
- DEFA14A Proxy Proxy Materials
- 8-K Event Other events
Page 3 of 16 · 316 filings